REQUEST A DEMO
Total
USD $0.00
Search more companies

Johnson And Johnson Medical Korea Limited (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Johnson And Johnson Medical Korea Limited Profile Updated: January 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Johnson & Johnson Medical Korea Ltd. is engaged in supply and distribution of medical devices and diagnostic equipment. The company is based in Seoul, South Korea. Johnson & Johnson Medical Korea Ltd. was established in 1988 and operates as a subsidiary of Johnson & Johnson SC.

Headquarters
92, Hangang-daero Yongsan-gu Seoul
Seoul; Seoul; Postal Code: 140012

Contact Details: Purchase the Johnson And Johnson Medical Korea Limited report to view the information.

Website: http://www.jnjmed.co.kr

Basic Information
Total Employees:
Purchase the Johnson And Johnson Medical Korea Limited report to view the information.
Outstanding Shares:
Purchase the Johnson And Johnson Medical Korea Limited report to view the information.
Registered Capital:
Purchase the Johnson And Johnson Medical Korea Limited report to view the information.
Incorporation Date:
December 23, 1988
Key Executives
Purchase this report to view the information.
CEO
Ownership Details
Purchase this report to view the information.
60.4%
Purchase this report to view the information.
39.6%
Subsidiaries
Janssen Vaccines Ltd.
Johnson & Johnson Korea Selling & Distribution Llc
Johnson And Johnson Korea Ltd.
Company Performance
Financial values in the chart are available after Johnson And Johnson Medical Korea Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.49%
Total operating revenue
6.49%
Operating profit (EBIT)
-9.16%
EBITDA
-7.96%
Net Profit (Loss) for the Period
-46.51%
Total assets
8.01%
Total equity
9.71%
Operating Profit Margin (ROS)
-0.86%
Net Profit Margin
-3.89%
Return on Equity (ROE)
-10.06%
Debt to Equity Ratio
-0.46%
Quick Ratio
0.13%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?